PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |diabetes mellitus |
| Sentences | 139 |
| PubMedID- 24582090 | Cardiovascular disease in diabetes mellitus: risk factors and medical therapy. |
| PubMedID- 24918095 | Background: dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. |
| PubMedID- 25326996 | Complications of diabetes mellitus include cardiovascular diseases, retinopathy, neuropathy and diabetic foot, which can in turn lead to lower extremity amputations. |
| PubMedID- 24617860 | Context: dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus (dm). |
| PubMedID- 25391871 | Objective: to explore the change and possible role of blood lipids during the course of plaque formation induced by diabetes mellitus in patients with ischemic cerebral vascular disease. |
| PubMedID- 20530022 | Management of diabetes mellitus in patients with cardiovascular disease in the bypass angioplasty revascularization investigation 2 diabetes (bari 2d) trial. |
| PubMedID- 26381503 | Erythropoiesis stimulating agent (esa) treatments targeting mild anemia (10-12 g/dl) can decrease the risk of occurrence of cardiovascular disease (cvd) in patients with hypertension, diabetes mellitus and congestive heart failure. |
| PubMedID- 20186491 | We then discuss the implications of these studies for current management and for new approaches for the prevention and treatment of cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 21359028 | [28] although the metabolic syndrome unequivocally predisposes to type 2 diabetes mellitus,[29] many investigators of cardiovascular diseases consider this syndrome a multidimensional risk factor for ascvd. |
| PubMedID- 19232762 | Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus--a pooled meta-analysis of randomized placebo-controlled clinical trials. |
| PubMedID- 19859073 | The burden of microvascular disease in patients with type 2 diabetes mellitus continues to escalate worldwide. |
| PubMedID- 26473035 | Moreover, microalbuminuria is associated with cardiovascular disease in patients with diabetes mellitus [7] and in the general population [8]. |
| PubMedID- 20920271 | However, with the occurrence of dysfunction, the endothelium is a potential contributor to the pathogenesis of vascular disease in diabetes mellitus and atherosclerosis [12]. |
| PubMedID- 20040043 | [37] to suggest that rosiglitazone may contribute to a decrease in the development of vascular diseases associated with type 2 diabetes mellitus through actions on pecam-1. |
| PubMedID- 24094079 | The risk of cardiovascular disease in diabetes mellitus is pushed sharply higher by hypercholesterolemia, especially elevated low-density lipoprotein cholesterol (ldl-c). |
| PubMedID- 21398276 | Circulating angiopoietic cells and diabetic retinopathy in type 2 diabetes mellitus, with or without macrovascular disease. |
| PubMedID- 21390057 | Pulse pressure and systolic night-day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 24855344 | Several large-scale, prospective, randomized trials have documented that lowering glycemic levels can prevent the development of microvascular disease in people with type 2 diabetes mellitus (t2dm). |
| PubMedID- 25256018 | Aims: this study aimed to investigate the impact of early-onset diabetes on the risk of microvascular diseases in chinese with type 2 diabetes mellitus (t2dm). |
| PubMedID- 24977070 | Patients were excluded for the following reasons: age over 75 or under 55, previous surgery to the index joint, inflammatory arthritis, relevant comorbidity (tumors, diabetes mellitus, history of respiratory disease, cardiovascular disease, mental health problems, musculoskeletal system diseases, previous endocrinological diagnosis) or refusal to answer to the questionnaires. |
| PubMedID- 20701768 | Risk factor reduction is the most important therapy for primary and secondary prevention of macrovascular disease in patients with and without diabetes mellitus. |
| PubMedID- 24462067 | Results of epidemiologic studies that investigated the significance of pulse pressure (pp) and mean arterial pressure (map) in terms of risk of cardiovascular disease (cvd) in patients with diabetes mellitus are inconsistent. |
| PubMedID- 22230215 | The mean egfrs, adjusted for age (continuous variable), sex, comorbid hypertension and diabetes mellitus, and history of cardiovascular diseases by multiple linear regression models, were compared between genotypes using the homozygous for the major allele as the reference. |
| PubMedID- 24158454 | The framingham stroke prediction algorithm (http://www.framinghamheartstudy.org/risk/stroke.html) included sbp values and age, diabetes mellitus, smoking, history of cardiovascular disease, presence of atrial fibrillation, left ventricular hypertrophy and the use of hypertensive medication. |
| PubMedID- 22906083 | Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care. |
| PubMedID- 25179966 | Peripheral neuropathy may be a potential risk of cardiovascular disease in diabetes mellitus. |
| PubMedID- 24920930 | Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. |
| PubMedID- 23466101 | Objectives: low levels of blood adiponectin contribute to an increased risk of cardiovascular disease (cvd) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 24049653 | It was determined in many multiple independent longitudinal studies that the hp genotype is an independent determinant of the risk of incident cardiovascular disease in individuals with diabetes mellitus (dm) [146–151]. |
| PubMedID- 23466074 | Role of relationship between hba1c, fibrinogen and hdl-cholesterol on cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 26244041 | A recent review identified twelve risk equations for the prediction of cardiovascular disease in subjects with type 2 diabetes mellitus (t2dm) [6]. |
| PubMedID- 22347652 | The mechanisms underlying the increased risk of cardiovascular disease associated with diabetes mellitus (dm) are not fully defined. |
| PubMedID- 24728837 | The presence of cardiovascular diseases was significantly associated with diabetes mellitus in patients with copd. |
| PubMedID- 26038692 | Although diabetes mellitus is associated with increased vascular disease, it has not been described as a cause of severe pituitary hypofunction because of the protection provided by the many vessels that feed the circle of willis. |
| PubMedID- 25554536 | Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease. |
| PubMedID- 26485682 | Sympathetic abnormalities play an important role in the pathophysiology of cardiovascular disease associated with metabolic syndrome, diabetes mellitus and obesity [1–4]. |
| PubMedID- 23227510 | [a current model for predicting the risk of cardiovascular diseases in patients with type 2 diabetes mellitus]. |
| PubMedID- 23245213 | Background: abnormal circadian blood pressure patterns have been associated with cardiovascular disease in diabetes mellitus. |
| PubMedID- 24500563 | Despite the profound clinical importance of vascular disease in patients with diabetes mellitus, our understanding of the relative contributions of insulin resistance and hyperglycemia to atherogenesis is not complete. |
| PubMedID- 22615952 | Model 1: adjusted for age, bmi, current smoking, alcohol intake, exercise, diabetes mellitus, history of cardiovascular disease and history of malignancy. |
| PubMedID- 26413719 | We also adjusted for body mass index and comorbidities including hypertension, diabetes mellitus and history of cerebrovascular disease (model 2, table 3). |
| PubMedID- 22447230 | This manuscript presents an overview of the biology of the haptoglobin genotype and reviews the literature concerning its role in the development of cardiovascular disease among individuals with diabetes mellitus. |
| PubMedID- 20653327 | Therapeutic potential of aleglitazar, a new dual ppar-alpha/gamma agonist: implications for cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 22291824 | We assessed the long-term effects of multifactorial intervention on lfts and their association with cardiovascular disease (cvd) events in patients with mets without diabetes mellitus or cvd. |
| PubMedID- 21933841 | Purpose: to evaluate myocardial microvascular disease in patients with type 2 diabetes mellitus (dm) using myocardial contrast echocardiography (mce) and to report on its diagnostic accuracy using single photon emission tomography (spect) as reference test. |
| PubMedID- 24567354 | Increased white blood cell (wbc) count is related to cardiovascular disease in patients with type 2 diabetes mellitus; raised neutrophil lymphocyte ratio (nlr) is associated with metabolic syndrome. |
| PubMedID- PMC4033993 | However, use of aspirin in primary prevention of cardiovascular disease, or in patients with diabetes mellitus, or in those with peripheral vascular disease is not supported by the current evidence. |
| PubMedID- 21990060 | [cardiovascular disease patients with diabetes mellitus type 2]. |
| PubMedID- 25526571 | Key words: vitamin d, diabetes mellitus, deficiency of vitamin d, cancer, cardiovascular diseases, muscle physiology. |
| PubMedID- 23433125 | Simultaneous pancreas-kidney transplantation (spk) is an advanced treatment option for type 1 diabetes mellitus (dm) patients with microvascular disease including nephropathy. |